{"nct_id":"NCT04951219","title":"A Phase 3 Study to Evaluate Safety and Biomarkers of Resmetirom (MGL-3196) in Patients With Non-alcoholic Fatty Liver Disease (NAFLD), MAESTRO-NAFLD-Open-Label-Extension (MAESTRO-NAFLD-OLE)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2021-07-09","start_date_type":"ACTUAL","primary_completion_date":"2026-03","primary_completion_date_type":"ESTIMATED","completion_date":"2026-04","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["MDGL"]}